patent semaglutide Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the protecting Novo Nordisk's expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants Massive Rs 50,000 Cr Opportunity

The threads also stimulate collagen production, which further diminishes the appearance of fine lines and wrinkles

Regular physical activity stimulates colonic motility through multiple mechanisms, including increased abdominal muscle tone and enhanced parasympathetic nervous system activity

The seven risk groups to watch Practical ways to reduce your risk When to consider alternatives or adjustments GLP-1 receptor agonists like Semaglutide and Tirzepatide have become go-to treatments for sustainable weight loss and improved blood sugar control

Tirzepatide's terminal half-life in humans is about 5 days

For pharma manufacturers, biosimilar developers, independent pharmacy operators, and plan sponsors, each of these pressures translates directly into formulary access risk, reimbursement rate volatility, and contract renegotiation exposure